Jeff Ryckman Henning Willers, MD Drew Moghanaki 🐕 Laura Dawson Shankar Siva Jake Scott Florian J. Fintelmann Since you mentioned single fraction… 😎

I’m presenting feasibility/acute toxicity outcomes of our multi-center SMART ONE trial at #ESTRO24 on Sunday

0.35T MRL, 25-40 Gy x 1

~1/3 lung, ~2/3 liver, adrenal, abdominal/pelvic LN, pancreas

~1/2 online adapted

🔥🔥 plans!

“The TIME Magazine 100 List for Healthcare? That’s cool & all, and I’m happy for Tom Powles, but I personally have always been after this shiny piece of metal …”

Behold — the Uromigos cup.

#UromigosLive24
#TeamLA : Tanya Dorff Petros Grivas
Uromigos.org

Generally a fan of #EAU #ESTRO etc guidelines. But curious why focal RT boost of tumor gets “weak” rating and ePLND gets “strong” 🤔

Only one of these has phase 3 RCT evidence of ⬇️ recurrence, ⬆️nodal/distant MFS, w/o toxicity increase.

Reconsider for 2025? ESTRO European Association of Urology (EAU)

50-day free link to our work here -
➡️ authors.elsevier.com/c/1j02A5EIIgPd…

The Lancet Oncology #radonc #kcsm . Peter Mac Radiation Oncology Sandro Porceddu

OLIGOPELVIS and the “All You Can Eat” Strategy for Oligorecurrent Nodal Prostate Cancer: Are We Already Full? ⁦Piet Ost⁩ ⁦Shankar Siva⁩ ⁦Supiot Stéphane⁩ ⁦Paul Sargos⁩ sciencedirect.com/science/articl…

We will see if our “experts” are doing the right thing. Although I still love Shankar Siva “eat, sleep, SABR, repeat!” So what is the correct endpoint for SABR vs whole pelvis.

Advancements in cutting-edge SABR therapy for oligometastatic #KidneyCancer . Shankar Siva Peter Mac Cancer Centre joins Alicia Morgans, MD, MPH Dana-Farber to discuss the innovative use of this therapy and its effectiveness in achieving local control > bit.ly/3WbPbyL

📢European Association of Urology (EAU) interview with Phillip Pierorazio about the role of SABR for primary #kidneycancer . Some penetrating questions prompted by FASTRACK II trial;
➡️ What do you counsel patients about long-term complications?
➡️ Is surgery possible after #radonc ?
shorturl.at/blzKL
#kcsm

Elliot Servais, MD, FACS It's also noteworthy to add this table to the discussion

A nationwide Dutch study (ESLUNG) demonstrates similar OS for stage I NSCLC treated with Lobectomy or SABR (HR 0.89, 95 % CI 0.65–1.20). #radonc #CSP2005 sciencedirect.com/science/articl…

Check it out!!! 😃

Clinical-research fellowships in radiation oncology at Peter Mac Cancer Centre! 🇦🇺

Apply here ➡️ careers.petermac.org/job/MELBOURNE-…

Just Out in the RED journal ASTRO 🇺🇸

The POP-RT trial 🇮🇳found that whole pelvic radiotherapy ☢️for high/very high-risk #ProstateCancer :

➡️resulted in comparable long-term urinary toxicity and quality of life to prostate-only radiotherapy, with no identified significant…

1/ The long-awaited OS results from #KEYNOTE -564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC .

nejm.org/doi/full/10.10…

📢🔈And then on the other hand... just breaking this month - jamanetwork.com/journals/jama/… - 19 of 46 cancer drugs (41%) granted accelerated FDA approval from 2013-2017 did not improve overall survival in confirmatory trials; 🧐 #radonc

Shankar Siva Stefanie Corradini 🌟 Ane Appelt Sociedad Chilena de Radioterapia Oncológica Alejandro (Ale) Berlin Alan Dal Pra, MD Drew Moghanaki 🐕 Peter Mac Radiation Oncology Targeting Cancer Sandro Porceddu Alfredo Addeo MD Enrique Grande Hernan Letelier It was a pleasure hosting you this week in 🇨🇱 Shankar Siva. We learned about kidney and lung SBRT, had tons of laughs, and the most important message - the most significant benefit of collaborative research is being part of something bigger! This is the way to move the field 💪🏻

Sandra Turner Here it is a different way annualized for the US market.

Last day of the National Congress Sociedad Chilena de Radioterapia Oncológica with our team and our guests Shankar Siva and Ane Appelt (and a 🦙 ) It has been a great honor and privilege to have you at our event! 🙌🏽☢️🫶🏽

💥 🌵✈️ That’s a wrap for me at Society of Chilean 🇨🇱 #radonc congress 2024 - a great well run meeting rb.gy/irpjms with talks also from Stefanie Corradini 🌟 and Ane Appelt! I must say, the Sociedad Chilena de Radioterapia Oncológica organisers were wonderful hosts…. 🙏🏽 Thank you! #radiotherapy